Albuterol sulfate and Gingival bleeding - a phase IV clinical study of FDA data

Summary:

Gingival bleeding is reported as a side effect among people who take Albuterol sulfate (albuterol sulfate), especially for people who are female, 60+ old, also take Zometa, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Gingival bleeding when taking Albuterol sulfate. It is created by eHealthMe based on reports of 76,282 people who have side effects when taking Albuterol sulfate from the FDA, and is updated regularly.

What is Albuterol sulfate?

Albuterol sulfate has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 77,268 Albuterol sulfate users. Check the latest studies of Albuterol sulfate.

What is Gingival bleeding?

Gingival bleeding (bleeding gums) is found to be associated with 1,027 drugs and 1,082 conditions by eHealthMe. Check the latest studies of Gingival bleeding.

On Jul, 19, 2026

76,282 people reported to have side effects when taking Albuterol sulfate.
Among them, 47 people (0.06%) have Gingival bleeding.

Could Albuterol sulfate cause Gingival bleeding?

Among these 47 people:

What is the gender of people who have Gingival bleeding when taking Albuterol sulfate? *

female: 79.55 %
male: 20.45 %

What is the age of people who have Gingival bleeding when taking Albuterol sulfate? *

What are other drugs people take besides Albuterol sulfate? *

What are other side effects people have besides Gingival bleeding? *

Stress And Anxiety: 23 people, 48.94%
Back Pain: 22 people, 46.81%
Swallowing Difficulty: 22 people, 46.81%
Anaemia (lack of blood): 21 people, 44.68%
Pain In Jaw: 21 people, 44.68%
Pain: 21 people, 44.68%
Fall: 20 people, 42.55%
Bone Disorder: 19 people, 40.43%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 18 people, 38.30%
Hip Fracture: 18 people, 38.30%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 3 people, 6.38%
Amyloidosis Senile (common form of amyloidosis in very old people, usually mild and limited to the heart): 2 people, 4.26%
Hepatitis C: 2 people, 4.26%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 4.26%
Immunodeficiency Common Variable: 2 people, 4.26%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 4.26%
Osteoporosis (bones weak and more likely to break): 2 people, 4.26%
Primary Immunodeficiency Syndrome: 2 people, 4.26%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 4.26%
Cardiac Amyloidosis (protein deposition in heart): 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Albuterol sulfate and have Gingival bleeding?

- Check whether Gingival bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Albuterol sulfate:

Albuterol sulfate (77,268 reports)

Browse all side effects of Albuterol sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingival bleeding:

Gingival bleeding (1,027 drugs)

Browse all the conditions that are associated with Gingival bleeding:

Gingival bleeding (1,082 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate (the active ingredients of Albuterol sulfate) and Albuterol sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.